Dementia is a broad clinical syndrome characterized by progressive cognitive decline affecting memory, reasoning, language, and daily function. It is caused by neurodegenerative diseases such as Alzheimer’s, vascular dementia, frontotemporal dementia, and Lewy body disease. With millions affected globally, dementia poses one of the greatest healthcare challenges of our time.

The Dementia session provides a platform to explore cutting-edge research in neuropathology, diagnostics, therapeutics, and caregiving strategies. Scientists are investigating molecular mechanisms including amyloid-beta aggregation, tau pathology, neuroinflammation, and vascular changes contributing to neurodegeneration.

At the Dementia Research Conference, experts discuss early detection using imaging, cerebrospinal-fluid biomarkers, and AI-based cognitive testing. Clinical updates include new drugs targeting protein misfolding and synaptic loss, as well as behavioral therapies improving quality of life. Non-pharmacological approaches—like cognitive training, music therapy, and digital interventions—are also gaining recognition for their long-term benefits.

This session is designed for neurologists, geriatricians, caregivers, and public-health specialists addressing dementia from research to real-world application. It also explores ethical and policy challenges, emphasizing the importance of global collaboration to reduce disease burden.

Ongoing findings from Neurodegeneration Research continue to inspire preventive and therapeutic advances for age-related brain decline.